This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is a lobbyist most likely permitted to do? a. Host a breakfast b. Wine ... (Read 28 times)

Garrulous

  • Hero Member
  • *****
  • Posts: 686
Which of the following is a lobbyist most likely permitted to do?
 
  a. Host a breakfast
  b. Wine and dine a member of Congress
  c. Take members of Congress on a golf vacation
  d. Sponsor a buffet dinner
  e. Give members of Congress tickets to sporting events

Question 2

Which of the following are considered demographic variables?
 
  a. age, gender, income, and bias
  b. gender, independence, income, and intelligence
  c. gender, age, and personality type
  d. income, gender, and age
  e. intelligence and income



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

xiazhe

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

Answer: A

Answer to Question 2

d




Garrulous

  • Member
  • Posts: 686
Reply 2 on: Jul 10, 2018
Gracias!


recede

  • Member
  • Posts: 315
Reply 3 on: Yesterday
Excellent

 

Did you know?

Women are two-thirds more likely than men to develop irritable bowel syndrome. This may be attributable to hormonal changes related to their menstrual cycles.

Did you know?

Less than one of every three adults with high LDL cholesterol has the condition under control. Only 48.1% with the condition are being treated for it.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

In 1835 it was discovered that a disease of silkworms known as muscardine could be transferred from one silkworm to another, and was caused by a fungus.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library